Abstract
The interest in employing enzymes in various types of practical applications has existed for many years. It is only within the last decade, however, that biochemists, chemical and biochemical engineers, food scientists, microbiologists, organic chemists, medical researchers, and others have cooperated in a significant interdisciplinary effort to solve the complex problems associated with the actual utilization of these superior catalysts. This effort has resulted in the development of techniques for binding enzymes to insoluble supports, methods for the design, construction, and optimization of various types of immobilized enzyme reactors and other advances that have provided a basis for a new field called enzyme engineering. Although enzyme engineering has been primarily aimed at establishing industrial applications, the technology that has been developed in this field has much to offer in the area of therapeutic medicine.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abderhalden, R., 1961, Clinical Enzymology, D. Van Nostrand Company, Inc., Princeton, N.J.
Abuchowski, A., van Es, T., Palczuk, N. C., and Davis, F. F., 1974, Preparation and properties of nonimmunogenic catalase, Federation Proc. 33: 1317.
Allison, J. P., Davidson, L., Gutierrez-Hartman, A., and Kitto, G. B., 1972, Insolubilization of L-asparaginase by covalent attachment to nylon tubing, Biochem. Biophy. Res. Commun. 47: 66.
Balaji, S., 1975, Stability and activity characteristics of collagen-immobilized hesperidinase, M.S. thesis, Rutgers University.
Benson, J. B., Gordon, M. S., and Patterson, J. A., 1967, Accelerated chromatographic analysis of amino acids in physiological fluids, Anal. Biochem. 18: 228.
Bernath, F. R., and Vieth, W. R., 1974, Collagen as a carrier for enzymes: materials science and process engineering aspects of chemical engineering, in: Immobilized Enzymes in Food and Microbial Chemistry ( A. Olson and C. Cooney, eds.), pp. 157–185, Plenum Press, New York.
Brady, R. O., Pentchev, P. G., and Gal, A. E., 1975, Investigations in enzyme replacement therapy in lipid storage diseases, Federation Proc. 34: 1310.
Broun, G., 1974, Trends in the use of immobilized enzymes and proteins in human therapeutics, in: Enzyme Engineering ( E. K. Pye and L. B. Wingard, eds.), pp. 433–438, Plenum Press, New York.
Capizzi, R. L., Bertino, J. R., and Handschumacher, R. E., 1970, L-Asparaginase, Ann. Rev. Med. 21: 433.
Chang, T. M. S., 1974, Effects of different routes of in vivo administration of microencapsulated enzymes, in Enzyme Engineering ( E. K. Pye and L. B. Wingard, eds.), pp. 419–424, Plenum Press, New York.
Chinitz, J., Yokoyama, T., Bower, R., and Schwartz, C., 1972, Self-sealing prosthesis for arteriovenous fistula in man, Trans. Amer. Soc. Artificial Internal Organs 18: 452.
Chvapil, M., Kronenthal, R. L., and VanWinkle, W., 1973, Medical and surgical applications of collagen, in International Review of Connective Tissue Research, Vol. VI ( D. A. Hall and D. S. Jackson, eds.), pp. 1–61, Academic Press, Inc., New York.
Constantinides, A., Vieth, W. R., and Fernandes, P. M., 1973, Characterization of glucose oxidase immobilized on collagen, Mol. Cellular Biochem. 1: 127.
Cooney, D. A., Weetall, H. H., and Long, E., 1975, Biochemical and pharmacologic properties of L-asparaginase bonded to dacron vascular prostheses, Biochem. Pharmacol. 24: 503.
Gregoriadis, G., 1975, Enzyme carrier potential of liposomes in enzyme replacement therapy, N. Engl. J. Med. 292: 215.
Hadden, J. W., 1974, Report from Sloan-Kettering: enzyme therapy and nutritional depletion of tumors, Clin. Bull. 4 (2): 72–74.
Heller, K. S., and Siskind, G. W., 1973, Effect of tolerance and of antibody mediated immune suppression on the avidity of the cellular and humoral immune response, Cellular Immunol. 6: 59.
Horvath, C., Sardi, A., and Woods, J. S., 1973, L-asparaginase tubes: kinetic behavior and applications in physiological studies, J. Appl. Physiol. 34: 181.
Ihler, G. M., Glew, R. H., and Schnure, F. W., 1973, Enzyme loading of erythrocytes, Proc. Natl. Acad. Sci. U.S. 70: 2663.
Innerfield, I., 1960, Enzymes in Clinical Medicine, McGraw-Hill Book Company, New York.
Katzman, H. E., Schild, A. F., and Vanderwerf, B. A., 1975, Bovine artegraft arteriovenous fistulas for hemodialysis in one hundred patients after conventional arteriovenous fistulas failed, J. Thoracic Cardiovascular Surg., submitted for publication.
Miyata, T., Sohde, T., Rubin, A. L., and Stanzel, K. H., 1971, Effects of ultraviolet irradiation on native and telopeptide-poor collagen, Biochim. Biophys. Acta 229: 672.
Nishihara, T., Rubin, A. L., and Stanzel, K. H., 1967, Biologically derived collagen membranes, Trans. Amer. Soc. Artificial Internal Organs 13: 243.
Oettgen, H. F., 1970, Clinical evaluation of L-asparaginase, in: Oncology, Vol. II: Experimental Cancer Therapy ( R. L. Clark, R. W. Cumley, J. E. McCay, and M. M. Copeland, eds.), p. 159, Year Book Medical Publishers, Inc., Chicago.
Paillot, B., Remy, M. H., Thomas, D., and Broun, G., 1974, Soluble crosslinked enzyme polymers: physicochemical properties, Pathol.- Biol. 22 (6): 491.
Pentchev, P. G., Brady, R. O., Hibbert, S. R., Gal, A. E., and Shapiro, D., 1973, Isolation and characterization of glucocerebrosidase from human placental tissue, J. Biol. Chem. 248: 5256.
Rosenberg, N., Gaughran, E. R. L., Henderson, J., Lord, G. H., and Douglas, J. F., 1955, Use of segmental arterial implants prepared by enzymatic modification of heterologous blood vessels, Surg. Forum 6: 242.
Rubin, A. L. Riggio, R. R., Nachman, R. L., Schwartz, G. H., Miyata, T., and Stenzel, K. H., 1968, Collagen materials in dialysis and implantation, Trans. Amer. Soc. Artificial Internal Organs 14: 169.
Salzman, E. W., 1971, Role of platelets in blood-surface interactions, Federation Proc. 30: 1503.
Sampson, D., Hersh, L. S., Cooney, D., and Murphy, G. P., 1972, A new technique employing extracorporeal chemotherapy, Trans. Amer. Soc. Artificial Internal Organs 18: 54.
Schmeck, H. M., Jr., 1974, An enzyme used for rare disease, The New York Times, November 7, 1974.
Shier, W. T., and Trotter, J. T., III, 1975, Lectin—enzyme conjugates: potential site-specific agents for enzyme therapy, presented at 170th American Chemical Society National Meeting, Chicago, August 28, 1975.
Stenzel, K. H., Miyata, and Rubin, A. L., 1974, Collagen as a biomaterial, Ann. Rev. Biophy. Bioeng. 3: 231.
Venkatasubramanian, K., Vieth, W. R., and Bernath, F. R., 1974, Use of immobilized enzymes in blood treatment, in: Enzyme Engineering 2 ( E. K. Pye and L. B. Wingard, eds.), pp. 439–445, Plenum Press, New York.
Vieth, W. R., and Venkatasubramanian, K., 1976, Collagen-immobilized enzyme systems, in: Methods of Enzymology: Immobilized Enzymes (K. Mosbach, eds.), Academic Press, Inc., New York, in press.
Wilner, G. D., Nossel, H. L., and LeRoy, E. C., 1968, Aggregation of platelets by collagen, J. Clin. Ines. 47: 2616.
Wolf, M., and Ransberger, K., 1972, Enzyme Therapy, Vantage Press, New York.
Wolnak, B., 1972, Present and Future Technological and Commercial Status of Enzymes, Report PB-219636 National Technical Information Service, U.S. Department of Commerce, Springfield, Va.
Wriston, J. C., and Yellin, T. O., 1973, L-Asparaginase: a review, Adv. Enzymol. 39: 185.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Bernath, F.R., Olanoff, L.S., Vieth, W.R. (1977). Therapeutic Perspectives of Enzyme Reactors. In: Chang, T.M.S. (eds) Biomedical Applications of Immobilized Enzymes and Proteins. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2610-6_23
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2610-6_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2612-0
Online ISBN: 978-1-4684-2610-6
eBook Packages: Springer Book Archive